Latest Stories
2 Reasons PGNY is Risky and 1 Stock to Buy Instead
Over the past six months, Progyny has been a great trade, beating the S&P 500 by 5.2%. Its stock price has climbed to $25.68, representing a healthy 16.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons ADSK is Risky and 1 Stock to Buy Instead
Autodesk currently trades at $297.44 per share and has shown little upside over the past six months, posting a small loss of 4.6%. The stock also fell short of the S&P 500’s 11.2% gain during that period.
3 Reasons POWL Has Explosive Upside Potential
What a time it’s been for Powell. In the past six months alone, the company’s stock price has increased by a massive 51.4%, reaching $318.00 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons APPN is Risky and 1 Stock to Buy Instead
Appian’s 16.3% return over the past six months has outpaced the S&P 500 by 5%, and its stock price has climbed to $35.42 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Avoid CADE and 1 Stock to Buy Instead
Over the past six months, Cadence Bank has been a great trade, beating the S&P 500 by 16.8%. Its stock price has climbed to $42.80, representing a healthy 28% increase. This run-up might have investors contemplating their next move.
Renasant (RNST): Buy, Sell, or Hold Post Q3 Earnings?
Over the last six months, Renasant’s shares have sunk to $35.22, producing a disappointing 5.3% loss - a stark contrast to the S&P 500’s 11.2% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Live Oak Bancshares (LOB): Buy, Sell, or Hold Post Q3 Earnings?
Live Oak Bancshares has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 10.1% to $34.35 per share while the index has gained 11.2%.
EMCOR (EME): 3 Reasons We Love This Stock
EMCOR trades at $617 and has moved in lockstep with the market. Its shares have returned 16.2% over the last six months while the S&P 500 has gained 11.2%.
Enpro (NPO): Buy, Sell, or Hold Post Q3 Earnings?
Enpro trades at $214.18 and has moved in lockstep with the market. Its shares have returned 9.7% over the last six months while the S&P 500 has gained 11.2%.
2 Reasons to Like CNXC (and 1 Not So Much)
Concentrix’s stock price has taken a beating over the past six months, shedding 26.1% of its value and falling to $41.58 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.